Insights from Digital Pharma Leaders
Refine Search
Pharmaceutical
BenevolentAI, a UK artificial intelligence (AI) company focused on health and drug development, has announced a new collaboration, with Swiss giant Novartis. 6 September 2019
Pharmaceutical
Pharma and other health companies are buying big into the artificial intelligence (AI) space, and the UK’s Health Secretary has now given this technology a major vote of confidence too. 8 August 2019
Biotechnology
A company that calls itself the world-leading AI-driven drug discovery company has entered into a collaboration with Rallybio, a privately-held development-stage biotechnology company focused on rare diseases. 23 July 2019
Pharmaceutical
IBM Watson Health has seen that being thought of as a pioneering company in applying artificial intelligence (AI) in healthcare can have its pros and cons, from a publicity point of view. 2 July 2019
Pharmaceutical
French pharma major Sanofi has gone big in its latest effort to address the perennial problem of how to speed up medical innovation. 18 June 2019
Pharmaceutical
Merck & Co is to participate in a US Food and Drug Administration (FDA) pilot program that uses blockchain technology to improve the way medicines are identified, tracked and traced within the USA. 13 June 2019
Pharmaceutical
The life sciences arm of Google-parent company Alphabet, Verily, has announced that four of the world’s leading pharma companies have joined its Project Baseline initiative. 22 May 2019
Pharmaceutical
In a previous incarnation, Boehringer Ingelheim chief financial officer Michael Schmelmer spearheaded a bold approach to innovation which could bear digital fruit for the 130 year-old family-owned drugmaker. 10 May 2019
Pharmaceutical
Japanese firms Eisai and Allm have agreed terms for a capital and business alliance agreement related to ICT digital health solutions and regional medical treatment and care. 9 May 2019
Pharmaceutical
The pharmaceutical industry is adopting artificial intelligence (AI) on numerous fronts, from discovery and clinical development to risk assessment and safety monitoring, regulatory, and manufacturing. 8 May 2019
Pharmaceutical
As pivotal changes in healthcare and drug development gain traction, new analysis from management consultancy Arthur D Little (ADL) highlights that all sectors of the industry must evolve their business and operating models in the coming decade. 2 May 2019
Pharmaceutical
At its annual general meeting in Frankfurt, Merck KGaA outlined plans to secure future growth, including ambitious goals in the contract manufacturing sector, and in digital technologies. 26 April 2019
Pharmaceutical
In an Expert View piece, Oliver Kidd, senior associate at Stevens & Bolton, provides an overview of an ever-more complex landscape. 24 April 2019
Pharmaceutical
South Korea CNS medicines specialist SK Biopharmaceuticals and twoXAR, a US artificial intelligence (AI)-driven biopharmaceutical company, today announced an agreement to discover and develop first-in-class therapeutics for non-small cell lung cancer (NSCLC). 18 April 2019
Pharmaceutical
German pharma major Bayer says it has neutralized a cyber threat present on its network for more than a year. 5 April 2019
Biotechnology
The Pan American Health Organization (PAHO) and non-profit PATH have published a report detailing the opportunities to improve vaccine programs through effective data use. 3 April 2019
Pharmaceutical
German life sciences group Bayer has combined its digital health programs to form the G4 Partnerships initiative. 21 March 2019
Biotechnology
US biotech major Celgene has become the latest drugmaker to team up with Exscientia, a privately-owned UK-based company that uses artificial intelligence (AI) in drug discovery. 21 March 2019
Biotechnology
Japanese drugmaker Ono Pharmaceutical has signed a drug discovery research collaboration with twoXAR, a USA-based artificial intelligence (AI)-driven biopharmaceutical company, to jointly discover and develop novel, efficacious treatments to address unmet medical needs in a specific neurological disease. 19 March 2019
Pharmaceutical
PureTech Health today announced that its independent affiliate Akili has entered into a strategic partnership with Japan’s Shionogi for the commercialization of two of Akili’s digital medicine product candidates. 7 March 2019
Pharmaceutical
An Expert View from Kevin Wild, head of pre-sales at software company Syniti. 23 January 2025
Pharmaceutical
The new US President has repealed an executive order from October 2023, signed by the Biden administration, that sought to establish rigorous safeguards for artificial intelligence (AI) development. 22 January 2025
Pharmaceutical
French pharmaceutical company Servier and Google Cloud have announced an expanded five-year partnership aimed at leveraging artificial intelligence (AI) and generative AI to accelerate drug research and development. 16 January 2025
Pharmaceutical
A collection of some of the largest US health systems, in collaboration with the Regeneron Genetics Center, have announced the launch of the Truveta Genome Project. 16 January 2025
Pharmaceutical
Privately-held Italian drugmaker Menarini and its oncology-focused subsidiary Stemline Therapeutics have entered into a licensing deal with AI-driven biotech Insilico Medicines. 15 January 2025
Biotechnology
Dyno Therapeutics, a privately-held US genetic technologies company applying AI to enable in vivo gene delivery, has announced that Roche has exercised its option to license a novel capsid for use in a gene therapy program for an undisclosed neurological disease indication. 13 January 2025
Pharmaceutical
Real-world evidence (RWE) specialist Atropos Health has announced a collaboration with US pharma giant Merck & Co. 13 January 2025
Biotechnology
Belgian biopharmaceutical company UCB has entered into a license agreement with Ailux Biologics, the biologics discovery division of XtalPi, to leverage its AI platform. 9 January 2025
Pharmaceutical
Insilico Medicine, a biotechnology firm specializing in artificial intelligence-powered drug discovery, has raised over $100 million in a series E funding round. 8 January 2025
Pharmaceutical
A team of Chinese researchers has identified a promising candidate for glaucoma treatment using artificial intelligence tools. 6 January 2025
Pharmaceutical
The market for artificial intelligence (AI) in cancer care is projected to grow from $2.2 billion in 2024 to $6.3 billion by 2029, reflecting a growth rate of 23.1%, according to a recent study by BCC Research. 31 December 2024
Biotechnology
AI-driven biotech BenevolentAI has announced sweeping changes aimed at refocusing its operations and extending its financial runway into 2027. 20 December 2024
Pharmaceutical
Shanghai-based Fangzhou, has entered into a strategic partnership with the Chinese business of Bristol Myers Squibb China, with the goal of enhancing digital platforms for chronic disease management. 19 December 2024
Pharmaceutical
Swedish biotech company Inify Laboratories has raised approximately 135 million kroner ($12.3 million) through a private placement, supporting a planned expansion into the UK. 16 December 2024
Pharmaceutical
The pharmacovigilance (PV) teams within the pharmaceutical industry currently report allocating 40 to 85% of budgets towards case processing. With case processing volumes growing at a rate of 10 to 15% annually, life sciences organizations are aiming to reduce costs and automate time-consuming processes while maintaining or improving quality. 9 December 2024
Biotechnology
Boston-based AI Proteins, a biotech that uses computational de novo protein design to create therapeutic miniproteins, has entered a research collaboration and option agreement with US pharma major Bristol Myers Squibb. 4 December 2024
Pharmaceutical
A Feature on M&A, licensing, and partnership tapping into AI’s potential to improve drug development. 2 December 2024
Biotechnology
AI-powered protein engineering company Cradle has raised $73 million in a Series B funding. The European firm, which has now raised more than $100 million in total, calls itself the leading platform for AI-powered protein engineering. 27 November 2024
Biotechnology
This week, we discuss a novel AI-driven approach to drug development, and its potential to transform the treatment of cancer and autoimmune diseases. 14 November 2024
Pharmaceutical
Digital therapeutics company GAIA has announced the signing of a licensing agreement for attexis with fellow German firm MEDICE Arzneimittel Pütter. 14 November 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze